Your browser doesn't support javascript.
loading
Lassa Virus Vaccine Candidate ML29 Generates Truncated Viral RNAs Which Contribute to Interfering Activity and Attenuation.
Johnson, Dylan M; Cubitt, Beatrice; Pfeffer, Tia L; de la Torre, Juan Carlos; Lukashevich, Igor S.
Afiliación
  • Johnson DM; Department of Microbiology and Immunology, School of Medicine, University of Louisville, Louisville, KY 40202, USA.
  • Cubitt B; Center for Predictive Medicine for Biodefense and Emerging Infectious diseases, University of Louisville, Louisville, KY 40202, USA.
  • Pfeffer TL; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • de la Torre JC; Center for Predictive Medicine for Biodefense and Emerging Infectious diseases, University of Louisville, Louisville, KY 40202, USA.
  • Lukashevich IS; Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY 402042, USA.
Viruses ; 13(2)2021 01 30.
Article en En | MEDLINE | ID: mdl-33573250
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Virales / Fiebre de Lassa / Virus Lassa Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Viruses Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Virales / Fiebre de Lassa / Virus Lassa Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Viruses Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos